Effects of dapagliflozin in Asian patients with heart failure and reduced ejection fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC: Asia, 2022 - jacc.org
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

[HTML][HTML] Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC Asia, 2022 - ncbi.nlm.nih.gov
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

Effects of dapagliflozin in Asian patients with heart failure and reduced ejection fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC: Asia, 2022 - eprints.gla.ac.uk
Background: Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives: This study sought to …

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC …, 2022 - research.regionh.dk
Background: Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives: This study sought to …

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang… - JACC …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC. Asia, 2022 - europepmc.org
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

[HTML][HTML] Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC: Asia, 2022 - Elsevier
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

KF Docherty, IS Anand, CE Chiang, VK Chopra… - ikm.ku.dk
Background: Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives: This study sought to …

Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.

KF Docherty, IS Anand, CE Chiang, VK Chopra… - JACC. Asia, 2022 - europepmc.org
Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …